6N8-21859-43832
2 vaccinations
0 coded responses
4 check-ins
0 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 852 / AZ
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-31
Dose 1 — Pfizer-BioNTech
-
2021-02-21
Dose 2 — Pfizer-BioNTech
-
2021-02-22
Registered in v-safe
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Nausea, Vomiting, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-22
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Chills, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-23
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-24
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-08-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-31 | Pfizer-BioNTech | |
| 2 | 2021-02-21 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-22 | priority 2/3 | |
| 2021-02-23 | priority 2/3 | |
| 2021-02-24 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.